Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 186 for your search:
Drug:  therapeutic hydrocortisone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: MAYO-803201

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 55
Sponsor: NCI
Protocol IDs: DFCI-79049, NCI-T84-0176D, T84-0176

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: POG-8698

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: SJCRH-AML-87, NCI-T86-0203D, T86-0203

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8862

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8820

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 through 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9405, POG-ALINC-16/SR

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 1 + under 20 at diag.
Sponsor: NCI
Protocol IDs: CCG-1941

10.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: PD-1003-01, NCI-V94-0598

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 60
Sponsor: Other
Protocol IDs: EORTC-06951, FRE-LALA-94, NCT00002700

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI, Other
Protocol IDs: 1952, CCG-1952, CDR0000064665, NCT00002744

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 6 months to under 21
Sponsor: NCI, Other
Protocol IDs: 5961, COG-C5961, CCG-5961, SFOP-LMB-96, CCLG-NHL-9600, EU-96048, CDR0000064702, NCT00002757

14.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: any age
Sponsor: NCI, Other
Protocol IDs: CDR0000064708, U10CA031946, CLB-9583, CALGB-9583, NCT00002760

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: NCI-2012-01834, 2961, U10CA098543, CDR0000064883, COG-2961, CCG-2961, NCT00002798

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI, Other
Protocol IDs: 1951, CCG-1951, CDR0000064968, NCT00002816

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI, Other
Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-8892, CLB-E8892, SWOG-E8892, NCT00002881, E8892

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: SAKK 38/97, SWS-SAKK-38/97, EU-97037, NCT00003215

20.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: CDR0000066202, DFCI-95001, DFCI-FDR001197, NCI-G99-1651, NCT00004034

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 16
Sponsor:
Protocol IDs: MRC-LEUK-AML12CH, EU-98010, NCT00003436

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: A2971, COG-A2971, CCG-A2971, POG-A2971, CCG-29701, CDR0000066664, NCT00003593

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CDR0000066840, EORTC-58951, NCT00003728

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 15
Sponsor: NCI
Protocol IDs: POG-7220/21

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: POG-7420/21, MDAR-23, POG-ALINC-11
1     
New Search